229 related articles for article (PubMed ID: 29849120)
1. The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.
Park JJ; Park MH; Oh EH; Soung NK; Lee SJ; Jung JK; Lee OJ; Yun SJ; Kim WJ; Shin EY; Kim EG
Oncogene; 2018 Sep; 37(38):5147-5159. PubMed ID: 29849120
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma.
Kang HW; Piao XM; Lee HY; Kim K; Seo SP; Ha YS; Kim YU; Kim WT; Kim YJ; Lee SC; Kim WJ; Shin EY; Kim EG; Yun SJ
Investig Clin Urol; 2021 Jul; 62(4):399-407. PubMed ID: 34085786
[TBL] [Abstract][Full Text] [Related]
3. p21-Activated kinase 4 promotes prostate cancer progression through CREB.
Park MH; Lee HS; Lee CS; You ST; Kim DJ; Park BH; Kang MJ; Heo WD; Shin EY; Schwartz MA; Kim EG
Oncogene; 2013 May; 32(19):2475-82. PubMed ID: 22710715
[TBL] [Abstract][Full Text] [Related]
4. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
[TBL] [Abstract][Full Text] [Related]
5. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
6. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
8. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
[TBL] [Abstract][Full Text] [Related]
9. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
10. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.
Liu YN; Abou-Kheir W; Yin JJ; Fang L; Hynes P; Casey O; Hu D; Wan Y; Seng V; Sheppard-Tillman H; Martin P; Kelly K
Mol Cell Biol; 2012 Mar; 32(5):941-53. PubMed ID: 22203039
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
13. A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.
Kesanakurti D; Maddirela D; Banasavadi-Siddegowda YK; Lai TH; Qamri Z; Jacob NK; Sampath D; Mohanam S; Kaur B; Puduvalli VK
Oncogene; 2017 Sep; 36(37):5309-5320. PubMed ID: 28534509
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
15. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
16. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
19. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
20. pSlug
Woo CG; Son SM; Lim YH; Lee D; Park JJ; Kim EG; Shin EY; Lee OJ
Virchows Arch; 2022 Feb; 480(2):449-457. PubMed ID: 34510267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
